Accessing Psilocybin in the UK
A debate on ‘Psilocybin Access Rights’ is expected to be heard in the House of Commons later this month. The session, scheduled for three hours, provides an opportunity for MPs to advocate for the rescheduling of psilocybin to enable better access to the psychedelic medicine.
The enhanced ability to recognise patterns is a property of the psychedelic experience consistently noted in clinical trials.
One’s ability to notice patterns, however, does not need enhancing to notice a sobering parallel between the legacy of earlier research from the Centre for Psychedelic Research at Imperial College London on psilocybin and the launch of the world’s largest medical psilocybin access and data project, Project Solace.
Both involve British innovation, but in the UK, psilocybin remains subject to the strictest possible scheduling in British law, meaning its enormous potential benefits to public health are under wraps on home turf and reaped exclusively in other jurisdictions.READ MORE